ChemoCentryx (CCXI) PT Raised to $60 at H.C. Wainwright

January 24, 2020 7:24 AM EST Send to a Friend
H.C. Wainwright analyst Edward White raised the price target on ChemoCentryx (NASDAQ: CCXI) to $60.00 while maintaining a Buy rating.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login